How to Get Finasteride in West Virginia

What Finasteride Is and Why Doctors Prescribe It

Finasteride is a 5-alpha-reductase type II inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen most responsible for follicle miniaturization in androgenetic alopecia and prostate enlargement in BPH. The FDA first approved the 5 mg tablet (Proscar) for BPH in 1992 and the 1 mg tablet (Propecia) for male-pattern hair loss in 1997 [1]. Generic versions of both doses have been available since the mid-2000s and are dispensed at virtually every pharmacy in West Virginia.

The drug's mechanism is well-characterized. A single 1 mg oral dose reduces serum DHT by approximately 65-70% within 24 hours [2]. That suppression is reversible: DHT returns to baseline within roughly 14 days of stopping the drug, which means hair loss often resumes at its prior rate after discontinuation [3].

Kaufman et al. (J Am Acad Dermatol 1998, N=1,553) found that 83% of men taking 1 mg finasteride daily maintained or increased hair count over 2 years, versus 28% on placebo (P<0.001) [4]. A separate 5-year open-label extension showed continued benefit with no additional safety signals at that duration [5].

For BPH, the 4-year PLESS trial (N=3,040) showed finasteride 5 mg reduced the risk of acute urinary retention by 57% and the need for BPH-related surgery by 55% compared with placebo [6]. The American Urological Association 2021 BPH guideline lists 5-alpha-reductase inhibitors as a recommended option for men with enlarged prostates and moderate-to-severe lower urinary tract symptoms [7].

How West Virginia Law Governs Finasteride Prescribing

West Virginia requires a valid prescriber-patient relationship before any Schedule-exempt prescription drug is dispensed. That relationship can be established in person or via synchronous audio-video telehealth under W. Va. Code §30-3-13a, which was amended in 2021 to align with post-pandemic standards [8]. Audio-only prescribing of finasteride without a prior in-person visit is not routinely accepted by most WV-licensed pharmacies, so video visits are strongly preferred.

Any clinician holding an active WV medical license may prescribe finasteride. That group includes MDs, DOs, nurse practitioners (with or without collaborative agreements under the 2022 NP full-practice-authority amendment), and physician assistants operating under a supervision agreement. The West Virginia Board of Medicine maintains a public license-verification portal where patients can confirm a prescriber's standing before their appointment [9].

Prescriptions may be transmitted electronically to any licensed WV pharmacy or to an out-of-state mail-order pharmacy that holds a WV non-resident pharmacy permit. The WV Board of Pharmacy lists all permit holders on its public website [10].

Getting Finasteride Through Telehealth in West Virginia

Telehealth is the fastest route for most WV residents, particularly those in rural counties where dermatology or urology waitlists can run 8-16 weeks. Several platforms are licensed to prescribe in West Virginia, including HealthRX.

The standard telehealth workflow for finasteride in WV follows four steps:

Step 1. Complete an intake questionnaire. The provider reviews your symptom history, current medications, and relevant past medical history. For hair-loss visits, photograph-based hair assessment tools such as the Norwood-Hamilton scale are often used asynchronously before the video call.

Step 2. Synchronous video consultation. The clinician confirms your identity, reviews your responses, discusses expected outcomes and side effects, and determines whether finasteride is appropriate. Most consultations run 15-25 minutes.

Step 3. Prescription issuance. If approved, the provider transmits an e-prescription to your preferred pharmacy or a partner mail-order pharmacy. A 30- or 90-day supply is typical for a first fill.

Step 4. Ongoing monitoring. Most telehealth platforms schedule a 90-day follow-up to assess tolerability and response, with annual PSA checks for men over 40 recommended by the FDA label [1].

The entire process from account creation to prescription in hand typically takes 2-5 business days when using mail-order, or as little as same day if you pick up locally.

Labs and Testing Required Before Starting Finasteride in WV

Most men starting finasteride for androgenetic alopecia do not need labs before the first prescription. The FDA-approved 1 mg label does not mandate baseline bloodwork [1]. For BPH patients, the picture is different.

A baseline PSA measurement is standard practice before initiating the 5 mg dose because finasteride reduces PSA by approximately 50% after 6 months of use [11]. Without a documented pre-treatment baseline, a PSA that doubles during therapy may be misread as a benign finasteride effect rather than a signal warranting prostate biopsy. The AUA 2021 BPH guideline states: "Clinicians should obtain a baseline PSA before initiating 5-ARI therapy and should counsel patients that a confirmed increase in PSA of greater than 0.3 ng/mL while on therapy warrants further evaluation" [7].

For hair-loss patients, some WV telehealth providers also order a baseline PSA for men over 40, a complete blood count to exclude alopecia driven by iron deficiency or thyroid dysfunction, and a thyroid-stimulating hormone (TSH) level. These are clinical preferences, not regulatory requirements. Lab orders can be sent electronically to LabCorp, Quest Diagnostics, or any independent WV laboratory, and most results return within 48-72 hours [12].

Liver function testing is rarely indicated. Finasteride undergoes hepatic metabolism via CYP3A4, but clinically significant hepatotoxicity is not documented in the published literature at therapeutic doses [3].

Finasteride Pharmacies in West Virginia: Chain, Independent, and 503A Compounding

Every major retail chain operating in West Virginia, including CVS, Walgreens, Walmart Pharmacy, and Kroger Pharmacy, stocks generic finasteride 1 mg and 5 mg tablets. GoodRx pricing for a 30-day supply of generic finasteride 1 mg at WV pharmacies ranges from approximately $10 to $28 as of mid-2025, depending on the dispensing pharmacy and coupon used [13].

Mail-order options expand access for residents in WV's 55 counties, many of which are classified as Health Professional Shortage Areas (HPSAs) by HRSA [14]. Mail-order pharmacies holding WV non-resident permits can ship 90-day supplies, which typically cost $15-$45 for generic finasteride without insurance.

503A compounding pharmacies licensed in West Virginia may prepare finasteride in alternative forms, most commonly a topical solution (0.25% or 1% finasteride in a propylene glycol base) for patients who prefer to minimize systemic DHT suppression. Topical finasteride is not FDA-approved as a finished dosage form, and the evidence base is smaller than for oral tablets. A 2020 randomized trial (N=71) found that topical finasteride 0.25% once daily produced 22% more hair growth by phototrichogram than placebo at 24 weeks, with serum DHT suppression of only 18-22% compared with 65-70% for oral finasteride [15]. Patients considering topical compounded finasteride should confirm that the 503A pharmacy holds an active WV permit and that the preparation is made in compliance with USP Chapter 795 standards [16].

WV Medicaid does not currently cover finasteride for androgenetic alopecia, as cosmetic indications are excluded from most state Medicaid formularies. Coverage for BPH indication may be available with prior authorization; documentation requirements are outlined in the section below.

Prior Authorization for BPH Patients on WV Medicaid

If a WV Medicaid enrollee needs finasteride 5 mg for BPH, prior authorization (PA) is the most common route to coverage. The typical documentation package includes a letter of medical necessity from the prescribing clinician, documentation of an enlarged prostate (either by digital rectal exam findings or prostate volume on ultrasound), an IPSS (International Prostate Symptom Score) of 8 or higher, and confirmation that at least one first-line behavioral or alpha-blocker trial was considered [7].

The WV Medicaid PA process averages 3-7 business days for routine reviews. Urgent reviews, available when a patient faces acute urinary retention risk, must be completed within 72 hours under federal Medicaid regulations [17]. If PA is denied, the prescriber may appeal through the WV DHHR's administrative hearing process.

Private insurance plans operating in WV under ACA marketplace rules generally cover generic finasteride for BPH with standard cost-sharing once medical necessity criteria are met. Hair-loss coverage remains rare across both commercial and government payers.

Transferring an Existing Finasteride Prescription to West Virginia

Patients relocating to WV with an active finasteride prescription from another state can transfer it to any WV-licensed pharmacy. Federal law permits a one-time transfer of a non-controlled prescription between pharmacies. Because finasteride is not a controlled substance, WV imposes no additional transfer restrictions [18].

To transfer, contact your new WV pharmacy with the original pharmacy's name, phone number, and your prescription number. The receiving pharmacist handles the transfer directly. If the original prescription has no refills remaining, the new pharmacy cannot add refills; the patient will need a new prescription from a WV-licensed provider.

Telehealth platforms that prescribe across multiple states can often issue a new WV prescription during a brief follow-up video visit, sometimes the same day the patient requests it. Most platforms retain prior visit records, so the clinical history does not need to be re-collected from scratch [8].

Side Effects, Monitoring, and When to Contact Your Provider

Finasteride's most discussed side effects are sexual: decreased libido, erectile dysfunction, and reduced ejaculate volume. The original Merck key trial reported these in 3.8% of men on 1 mg versus 2.1% on placebo; most resolved after stopping the drug [5]. A subset of patients report persistent sexual side effects after discontinuation, a cluster sometimes labeled post-finasteride syndrome (PFS). The FDA added a label update in 2012 noting that libido disorders, ejaculation disorders, and orgasm disorders may persist after stopping finasteride [1].

The FDA also requires a black-box warning regarding fetal exposure: finasteride is contraindicated in women who are or may become pregnant because of the risk of external genital abnormalities in a male fetus [1]. Women of childbearing potential should not handle crushed or broken finasteride tablets.

Monitoring during treatment should include:

• PSA at 6 months after starting 5 mg (BPH patients), then annually [7].
• Any confirmed PSA increase greater than 0.3 ng/mL during therapy warrants urology referral regardless of absolute PSA value [7].
• Annual symptom review for sexual side effects, with dose reduction or discontinuation discussed if quality of life is affected [11].
• Depression screening is reasonable given a small signal in published pharmacovigilance data, though a 2021 population-based cohort study (N=93,197) in JAMA Dermatology found no statistically significant increase in depression rates attributable to finasteride after propensity-score adjustment [19].

Patients should contact their WV provider promptly if they notice breast tenderness, nipple discharge, or a lump, as finasteride carries a rare risk of gynecomastia (reported in less than 1% of trial participants) [5].

What to Expect: Timeline for Results in West Virginia Patients

Hair loss results follow a predictable course. Three to six months of continuous daily use is the minimum before any visible change in hair density is expected, because the follicle growth cycle runs approximately 90 days [4]. Shedding may briefly increase in the first 4-8 weeks as telogen-phase hairs are displaced by new anagen growth; this is normal and not a sign of treatment failure [3].

By 12 months, clinical trials show a meaningful difference from baseline. At 24 months in the Kaufman 1998 study, the mean increase in hair count was 107 hairs per 1 cm2 target area versus a decrease of 50 hairs per 1 cm2 in the placebo group [4]. Hair density peaks around 2 years of use and then plateaus rather than continuing to increase [5].

BPH symptom relief follows a slower arc. Prostate volume reduction of approximately 20% requires 6-12 months of finasteride 5 mg daily, and maximum IPSS score improvement is typically observed at 12 months [6]. Alpha-blocker therapy (for example, tamsulosin 0.4 mg nightly) produces faster symptom relief and is often prescribed alongside finasteride during the first 6-12 months for men with severe baseline LUTS [7].

Cost and Insurance Coverage Summary for West Virginia Residents

Generic finasteride 1 mg costs approximately $10-$28 for a 30-day supply at WV retail pharmacies with discount programs [13]. The 5 mg generic runs slightly higher, roughly $15-$35 for 30 tablets, because it is dispensed less frequently and carries lower rebate pressure. Brand-name Propecia and Proscar are rarely dispensed given the cost differential; a 30-day brand supply can exceed $80-$100 without insurance.

WV Medicaid does not cover finasteride for hair loss. BPH coverage requires PA as described above. Most commercial plans cover generic finasteride for BPH at Tier 1 or Tier 2 cost-sharing once PA criteria are satisfied [17].

Manufacturer patient-assistance programs are not relevant for generic finasteride given the already-low cash price. Telehealth platform subscription fees vary: some charge $15-$25 per month inclusive of medication, while others bill a separate consultation fee of $40-$75 and issue a prescription to any pharmacy.